BeOne Medicines Ltd. ($ONC)
Filing Information
| Accession Number | 0001852291-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 15, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
349,156
Total Value
$197,317.59
P&L
+inf% (+$95,928,456.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Global Head of R&D | Ordinary Shares | โ | Jun 11, 2026 | Grant/Award | 118,625 | $0.00 | $0.00 | 1,710,085 | Direct | โ | View Details | |
President, Global Head of R&D | American Depositary Shares | โ | Jun 11, 2026 | Sale | 756 | $261.00 | $197,317.59 | 0 | Direct | โ | View Details | |
President, Global Head of R&D | Share Option (Right to Buy) | Derivative | Jun 11, 2026 | Grant/Award | 229,775 | $0.00 | $0.00 | 229,775 | Direct | โ | View Details |